Thyroplasty Surgery in India
Get Thyroplasty Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Thyroplasty Surgery in UAE
Thyroplasty Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Thyroplasty is a precise laryngeal framework surgery designed to restore or improve voice quality by repositioning or augmenting the vocal folds, achieving satisfactory voice rehabilitation in approximately 85–95% of carefully selected patients. International patients choose India and the UAE for this procedure due to access to fellowship-trained laryngologists, state-of-the-art voice laboratories, and significant cost advantages compared to Western healthcare systems. GAF Healthcare coordinates end-to-end medical journeys to JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centers in the UAE, ensuring world-class outcomes at transparent, competitive pricing.
Hospital Stay: 1–3 days • Total Stay in Country (Fit-to-Fly): 1–2 weeks • Success Rate: 85–95%
What Is It?
Thyroplasty, formally classified under phonosurgery and laryngeal framework surgery, is a set of procedures that alter the structural geometry of the thyroid cartilage to change the position, tension, or mass of the vocal folds. The most commonly performed variant — Type I Thyroplasty (medialization thyroplasty) — addresses unilateral vocal fold paralysis or paresis, a condition in which one vocal fold fails to reach the midline during phonation, resulting in a characteristic breathy, weak, or diplophonic voice, chronic aspiration, and compromised airway protection during swallowing. The underlying etiologies are diverse and include iatrogenic recurrent laryngeal nerve (RLN) injury following thyroid, parathyroid, or cardiothoracic surgery; idiopathic RLN paralysis; skull-base or neck malignancies; and neurological conditions such as Parkinson's disease.
Physiologically, an incompetent glottic closure creates a persistent posterior glottic gap during the adductory phase of phonation. This forces patients to compensate with supraglottic hyperfunction, leading to vocal fatigue, musculoskeletal tension dysphonia, and, critically, an inability to generate sufficient subglottic pressure for effective coughing — raising aspiration pneumonia risk significantly. Laryngostroboscopy, videolaryngoscopy, and acoustic voice analysis (measuring maximum phonation time, jitter, shimmer, and harmonics-to-noise ratio) are essential pre-operative benchmarks used to quantify glottic insufficiency and set rehabilitation goals.
The standard of care in high-volume laryngology centers has evolved considerably. Contemporary practice integrates awake, in-office procedures under local anesthesia — allowing real-time intraoperative voice monitoring — with implantable biomaterials such as Gore-Tex (expanded polytetrafluoroethylene), silicone, titanium vocal fold medializer systems (e.g., Montgomery implant, Netterville implant), and, for select cases, injectable vocal fold augmentation using hyaluronic acid, calcium hydroxylapatite (Radiesse Voice), or autologous fat. The choice between medialization laryngoplasty and arytenoid adduction (or a combined approach) is guided by the position of the paralyzed cord, the size of the posterior glottic gap, and patient-specific voice goals.
Candidates
• ELIGIBLE PATIENTS:
• Unilateral vocal fold paralysis or paresis confirmed on flexible laryngoscopy and laryngostroboscopy, with posterior glottic gap on phonation
• Presbylaryngis (age-related vocal fold atrophy) causing significant voice handicap (Voice Handicap Index score > 30)
• Vocal fold scarring or sulcus vocalis resulting in glottic insufficiency refractory to voice therapy
• Post-thyroidectomy, post-anterior cervical spine surgery, or post-cardiothoracic surgery RLN injury where nerve recovery is not expected beyond 12 months
• Patients who have failed or are not candidates for voice therapy alone
• Parkinson's disease or other neurolaryngological conditions causing hypophonia with glottic incompetence
• REQUIRED PRE-OPERATIVE DIAGNOSTICS:
• Flexible nasolaryngoscopy and high-definition videolaryngostroboscopy (gold standard for vocal fold mucosal wave assessment)
• Acoustic voice analysis: fundamental frequency (F0), jitter (<1.04%), shimmer (<3.81%), harmonics-to-noise ratio (HNR), maximum phonation time (MPT)
• Aerodynamic assessment: mean airflow rate, subglottic pressure estimation
• High-resolution CT of the larynx and neck (to evaluate cartilage framework and exclude malignancy)
• MRI of the brain, skull base, and entire RLN course (if central or skull-base cause is suspected)
• Swallowing evaluation: Fiberoptic Endoscopic Evaluation of Swallowing (FEES) or Modified Barium Swallow (MBS) if aspiration is a concern
• Electromyography (LEMG) of the laryngeal muscles (to determine RLN prognosis and differentiate paralysis from fixation)
• Pulmonary function tests and anesthesia fitness assessment for patients undergoing general anesthesia
• CONTRAINDICATIONS:
• Bilateral vocal fold paralysis with compromised airway (primary airway management takes priority)
• Active laryngeal or pharyngeal malignancy at the surgical site
• Uncontrolled systemic coagulopathy or anticoagulation that cannot be safely bridged
• Significant cartilage calcification that precludes precise thyroid cartilage windowing (relative contraindication; may require alternative implant or approach)
• Unrealistic patient voice expectations not aligned with achievable surgical outcomes
• Severe obstructive sleep apnea or compromised airway where medialization may reduce airway lumen critically
Procedure
STANDARD APPROACHES:
• Type I Medialization Thyroplasty (Isshiki Technique): The foundational procedure. A precisely dimensioned rectangular window is carved into the thyroid cartilage lamina under local anesthesia with intravenous sedation, allowing the surgeon to insert a carved or pre-formed implant that pushes the paralyzed vocal fold medially. Real-time voice assessment during surgery — with the awake patient phonating on command — allows iterative implant repositioning until optimal voice quality is confirmed acoustically and by laryngoscopy. Implants include hand-carved silicone blocks, pre-fabricated Montgomery implants, or titanium vocal fold medializer systems that offer adjustability.
• Arytenoid Adduction (Isshiki) / Arytenoid Adduction with Cricothyroid Subluxation: Indicated when there is a significant posterior glottic gap not adequately corrected by anterior medialization alone. A suture is passed around the muscular process of the arytenoid cartilage and tensioned anteriorly, rotating the arytenoid and adducting the posterior vocal process. This is typically combined with Type I thyroplasty for optimal results. Cricothyroid subluxation simultaneously adjusts vocal fold tension to correct pitch.
• Type II Thyroplasty (Lateralization): Used to widen the glottis in conditions such as bilateral adductor spasmodic dysphonia or bilateral vocal fold paralysis causing airway obstruction, achieving airway patency while attempting to preserve voice.
• Type III Thyroplasty (Relaxation/Shortening): Addresses muscle tension dysphonia and hyperfunctional voice disorders by shortening the vocal fold through anterior thyroid cartilage approximation.
• Type IV Thyroplasty (Cricothyroid Approximation): Elevates the fundamental frequency, primarily used in voice feminization surgery for transgender women (MTF), by permanently tensioning the vocal folds through approximation of the cricoid and thyroid cartilages.
MINIMALLY INVASIVE & ADVANCED APPROACHES:
• Injectable Vocal Fold Augmentation (In-Office or OR): Performed via transcutaneous, transoral, or transnasal routes under flexible endoscopic guidance. Materials include hyaluronic acid (temporary, 6–12 months), calcium hydroxylapatite (Radiesse Voice — semi-permanent, 12–24 months), carboxymethylcellulose, and autologous fat. Ideal for patients with early or potentially reversible paralysis, high surgical risk, or as a temporizing measure while awaiting RLN recovery. Offers same-session diagnosis and treatment with minimal recovery.
• Laser-Assisted Techniques: CO2 laser or KTP laser used adjunctively for scar lysis, mucosal contouring, or precise tissue modification during open framework surgery.
• Robotic-Assisted Approaches (Investigational/Select Centers): Transoral robotic surgery (TORS) platforms are being evaluated in select academic centers for enhanced precision in vocal fold procedures, minimizing external incisions.
• Laryngeal Reinnervation: For appropriately selected younger patients with RLN paralysis of less than 2–3 years' duration, ansa cervicalis-to-RLN anastomosis (Tucker reinnervation) may restore tonal muscle bulk and improve voice, sometimes combined with thyroplasty for immediate voice improvement while reinnervation matures.
Cost of Thyroplasty Surgery: India vs. UAE
The cost of Thyroplasty Surgery varies significantly depending on the destination, the complexity of the procedure (Type I alone versus combined Type I with Arytenoid Adduction), implant material selection, and the tier of hospital chosen. India offers highly competitive pricing — typically 50–65% lower than equivalent procedures in the UAE — while maintaining internationally accredited quality standards at NABH and JCI-certified hospitals. The UAE, particularly Dubai and Abu Dhabi, commands premium pricing reflective of its world-class infrastructure, luxury patient amenities, and proximity for patients traveling from the Middle East, Africa, and Europe. Both destinations significantly undercut comparable procedures in the United States (USD 15,000–30,000), United Kingdom, or Western Europe.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $2,500 – $5,500 | ~56% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $6,000 – $12,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — PRE-TRAVEL CONSULTATION (2–4 Weeks Before Arrival):
• GAF Healthcare coordinates a tele-consultation with the receiving laryngologist, during which the patient shares existing laryngoscopy videos, acoustic analysis reports, imaging studies, and medical history.
• The surgeon confirms candidacy, recommends the specific thyroplasty type or combination approach, and provides a personalized surgical plan.
• Pre-operative medical clearance workup is initiated locally (CBC, coagulation profile, ECG, anesthesia fitness) and results are transmitted digitally to the hospital.
• Anticoagulants (warfarin, NOACs, aspirin) and NSAIDs are discontinued per protocol (typically 5–7 days pre-operatively) with physician supervision.
• Visa documentation (e-Medical visa for India; visa arrangements for UAE) is managed by GAF Healthcare's concierge team.
PHASE 2 — ARRIVAL & PRE-OPERATIVE ASSESSMENT (Day 0–1):
• Airport pickup by GAF Healthcare's dedicated driver; transfer to pre-arranged hotel or hospital-adjacent accommodation.
• Day 1: Hospital admission for final pre-operative assessment — repeat flexible laryngoscopy, acoustic voice analysis baseline recording, anesthesia consultation, consent process, and marking.
• Blood work, cross-match, and final imaging reviewed by the surgical team.
• Nil by mouth (NPO) from midnight if general anesthesia planned; lighter restriction if local anesthesia with sedation.
PHASE 3 — SURGERY (Day 1 or 2, Duration: 1–3 Hours):
• Type I Medialization Thyroplasty (most common): Patient placed supine with neck slightly extended. A 4–5 cm horizontal cervical incision is made at the midthyroid level under local anesthesia and IV sedation. Subplatysmal flaps are elevated; strap muscles are separated to expose the thyroid cartilage lamina. A precisely measured rectangular window is created in the cartilage using an oscillating drill or curved chisels. The implant is carved and trial-sized, then inserted into the paraglottic space. The patient phonates in real time while the surgeon and voice technician assess quality acoustically and via simultaneous flexible laryngoscopy. The implant is adjusted until optimal glottic closure and voice quality are confirmed, then secured. The wound is closed in layers; a small Penrose or suction drain may be placed.
• Arytenoid Adduction (if combined): Performed through an extension of the same incision; the posterior lamina is elevated and arytenoid muscular process is identified and sutured.
• Intraoperative voice monitoring is the gold standard differentiator of high-quality centers.
PHASE 4 — IMMEDIATE POST-OPERATIVE PERIOD (Day 1–3, In Hospital):
• Strict voice rest for 24–48 hours post-operatively; communication via whiteboard or app.
• IV corticosteroids (dexamethasone) to minimize laryngeal edema; analgesics; prophylactic antibiotics.
• Drain removal typically at 24 hours; wound inspection.
• Flexible laryngoscopy on post-operative Day 2 to assess implant position, glottic closure, and exclude hematoma or edema.
• Swallowing assessment before resuming oral intake.
• Discharge typically Day 1–3 post-surgery.
PHASE 5 — EARLY RECOVERY IN-COUNTRY (Days 3–10, Hotel/Outpatient):
• Modified voice rest: 3–5 days of near-total voice rest, transitioning to limited conversational voice by Day 5–7.
• Outpatient follow-up at Days 5 and 10 for wound check, laryngoscopy, and acoustic voice analysis to document improvement.
• Swallowing monitored; soft diet maintained for 5–7 days.
• Patient is fit to fly internationally (short-to-medium haul) typically by Day 10–14 post-surgery, pending surgeon clearance.
PHASE 6 — RETURN HOME & LONG-TERM REHABILITATION:
• Structured voice therapy with a certified speech-language pathologist (SLP) commences 2–4 weeks post-operatively at the patient's home country.
• Goal: optimize glottic closure efficiency, eliminate compensatory supraglottic hyperfunction, and maximize the acoustic gains from surgery.
• Follow-up telemedicine consultations with the operating surgeon at 1 month, 3 months, and 6 months.
• Final acoustic analysis and laryngostroboscopy at 6 months to document definitive outcome.
• Long-term implant stability is typically excellent; revision rates for well-positioned implants are below 5%.
Risks & Considerations
Thyroplasty is generally considered a low-to-moderate-risk procedure, but patients must be counseled on procedure-specific and general surgical risks with transparency. The most immediately serious intraoperative risk is laryngeal edema, which, though uncommon, can compromise the airway and may rarely necessitate temporary intubation or tracheotomy. Post-operative hematoma formation in the neck (incidence <2%) demands urgent surgical re-exploration if it causes airway compression or swallowing difficulty, and patients are advised to return to the emergency department if they experience progressive neck swelling, stridor, or dyspnea in the first 48 hours. Implant-related complications include extrusion (rare, <1–2% with modern materials), over-medialization causing airway narrowing or voice quality that is too pressed/strained, and under-medialization requiring revision surgery. Infection at the implant site is uncommon (<1%) but may necessitate implant removal if severe. Wound-related risks — seroma, poor scar formation, or suture reaction — are generally minor and manageable. For patients undergoing arytenoid adduction simultaneously, there is a small risk of cartilage fracture, arytenoid dislocation, or suboptimal suture tension affecting posterior glottic closure. Voice outcomes, while excellent in high-volume centers, are probabilistic rather than guaranteed: approximately 85–95% of patients achieve a clinically significant and personally satisfying improvement in voice quality, but complete normalization of voice is not always achievable, particularly in long-standing paralysis (>2 years), significant vocal fold scarring, or severe nerve injury with muscle atrophy. A small proportion of patients (5–10%) may require a second procedure (revision or injectable augmentation) for optimal results. General anesthesia risks (cardiovascular, pulmonary, allergic) apply when the procedure is not performed under local anesthesia with sedation, and are assessed on an individual patient basis by the anesthesiology team pre-operatively.
Top Hospitals for Thyroplasty Surgery
Top Doctors for Thyroplasty Surgery
Internationally trained specialists in ENT. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. T. S. Kler
MBBS, MD (Medicine), DM (Cardiology), MRCP (UK), FRCP (UK), FACC (USA), D.Sc (Honoris Causa)
Interventional Cardiologist & Electrophysiologist
BLK-Max Super Speciality Hospital, New Delhi, India
37+ Yearsof experience
Dr. T. S. Kler is the Chairman and Head of Department at BLK-Max Heart & Vascular Institute and Chairman of Pan Max Electrophysiology, serving as a leading interventional cardiologist and electrophysiologist. With over 37 years of clinical excellence, he holds distinguished international credentials including FRCP (UK), FACC (USA), and an honorary D.Sc. from Punjab University, recognising his pioneering contributions to cardiology. Dr. Kler's clinical… Read more
Dr. Gopi Srikanth
MBBS, MD Internal Medicine, DM Gastroenterology and Hepatology, Fellowship in Pancreatology, Fellowship in Endoscopic Ultrasound
Gastroenterologist
Yashoda Hospitals, Hyderabad, India
10+ Yearsof experience
Dr. Gopi Srikanth is a Consultant Gastroenterologist and Hepatobiliary specialist at Yashoda Hospitals in Hyderabad, bringing over 10 years of clinical expertise in digestive and liver disease management. He holds a DM in Gastroenterology and Hepatology from AIIMS New Delhi and completed advanced fellowships in Pancreatology and Endoscopic Ultrasound from prestigious institutions including the World Endoscopy Organisation, which distinguish him as a… Read more
Dr. Guruprasad Shetty
MBBS, MS (General Surgery), DNB (General Surgery), FMAS, FIAGES, Fellowship in Surgical Gastroenterology and Minimally Invasive Surgery
Surgical Gastroenterologist & Hepatobiliary Surgeon
Apollo Hospitals, Mumbai, India
15+ Yearsof experience
Dr. Guruprasad Shetty is a Senior Consultant in Surgical Gastroenterology, Hepatopancreaticobiliary, and Transplant Surgery at Apollo Hospitals in Mumbai, bringing over 15 years of specialized surgical expertise. He holds exceptional credentials including MBBS, MS in General Surgery, DNB, FMAS (Fellowship in Minimal Access Surgery), and FIAGES, alongside a specialized fellowship in Surgical Gastroenterology and Minimally Invasive Surgery. His… Read more
Dr. Hitesh Panchal
MBBS, MD in Internal Medicine, DrNB in Gastroenterology
Gastroenterologist
Medanta - The Medicity, Gurgaon, India
9+ Yearsof experience
Dr. Hitesh Panchal is an Associate Consultant in Gastroenterology & Hepatobiliary Medicine at Medanta – The Medicity in Gurgaon, bringing 9+ years of clinical experience to the care of complex digestive and liver disorders. He completed his medical training at the esteemed B.J. Medical College, Ahmedabad, earning his MBBS in 2017 and MD in Internal Medicine in 2020, before pursuing his DrNB in Gastroenterology at Medanta, one of India's leading… Read more
Dr. Jatin Yegurla
MBBS, MD, DM
Gastroenterologist and Hepatologist
Apollo Hospital, Jubilee Hills, Hyderabad, India
10+ Yearsof experience
Dr. Jatin Yegurla is a Consultant Gastroenterologist and Hepatologist based at Apollo Hospital, Jubilee Hills in Hyderabad, with over 10 years of clinical expertise. He holds an MBBS degree, MD in Internal Medicine from PGIMER Chandigarh, and a DM in Gastroenterology, establishing a strong academic foundation in digestive health and hepatology. His comprehensive qualifications and sustained commitment to the specialty reflect his dedication to… Read more
Frequently Asked Questions — Thyroplasty Surgery
The total cost of Thyroplasty Surgery — encompassing surgeon fees, hospital charges, implant material, anesthesia, operating room costs, and a standard post-operative inpatient stay — typically ranges from USD 2,500 to USD 5,500 in India and from USD 6,000 to USD 12,000 in the UAE (Dubai or Abu Dhabi). These estimates cover a Type I Medialization Thyroplasty using a modern silicone or Gore-Tex implant; a combined procedure involving Arytenoid Adduction will be toward the upper end of each range due to increased operative time and complexity. India's cost advantage — approximately 50–65% lower than the UAE — is achieved without compromise in accreditation or technology: leading Indian hospitals performing this procedure hold both NABH and JCI accreditation, employ laryngologists trained at major US or UK institutions, and operate dedicated voice laboratories with laryngostroboscopy and acoustic analysis equipment. The UAE's higher pricing reflects its premium hospitality-grade infrastructure, luxury patient accommodation, and the particular convenience it offers to patients traveling from the Middle East, East Africa, and Europe who prefer a shorter flight. Both destinations represent exceptional value compared to the USD 15,000–30,000 benchmark cost of an equivalent procedure in the United States or United Kingdom. GAF Healthcare provides all patients with a fully itemized cost estimate before travel, with no hidden charges.
Most patients undergoing an uncomplicated Type I Medialization Thyroplasty can safely undertake international air travel approximately 10–14 days after surgery, subject to individual surgeon clearance at their final in-country follow-up visit. The breakdown of the in-country stay is as follows: 1–3 days of post-operative inpatient hospital stay for monitoring of airway, edema management, drain removal, and initial swallowing assessment; followed by 7–10 days of outpatient recovery in the country during which the patient attends follow-up laryngoscopy appointments (typically at Day 5 and Day 10 post-operatively) to confirm implant stability, adequate glottic closure, and absence of complications such as hematoma or wound infection. During this outpatient period, patients are on modified voice rest and a soft diet. Air travel is generally considered safe once the laryngeal edema has fully resolved, the wound is well-healed, and the surgeon is satisfied with the laryngoscopic appearance — criteria typically met by Day 10–14. Patients who undergo a more complex combined procedure (Type I Thyroplasty with Arytenoid Adduction) may require 14–21 days in-country due to the additional tissue handling and slightly longer healing curve. Patients with any signs of airway compromise, wound complication, or significant dysphagia will be advised to extend their stay until these are resolved, for which GAF Healthcare arranges accommodation extensions without surcharge.
Thyroplasty Surgery — particularly Type I Medialization Thyroplasty — achieves clinically significant and patient-reported voice improvement in approximately 85–95% of appropriately selected candidates when performed by experienced laryngologists in high-volume centers. Success is measured across multiple dimensions rather than as a single binary outcome. Objectively, success is documented by post-operative acoustic analysis showing improvement in maximum phonation time (MPT, target >10 seconds), reduction in jitter and shimmer values toward normative ranges, improved harmonics-to-noise ratio (HNR), and laryngostroboscopic confirmation of adequate glottic closure with minimal or absent residual glottic gap. Subjectively, validated patient-reported outcome instruments — primarily the Voice Handicap Index (VHI-10) and the GRBAS scale — are used to quantify the patient's perception of voice improvement in daily communicative function. In published literature, medialization thyroplasty consistently achieves mean VHI-10 score reductions of 60–75% from baseline. Swallowing safety outcomes are also tracked in patients presenting with aspiration, where approximately 80–90% demonstrate reduced aspiration events on post-operative FEES or modified barium swallow. Factors that favorably influence outcomes include surgery performed within 12 months of paralysis onset, absence of severe vocal fold atrophy or scarring, and active post-operative voice therapy with a certified SLP. The small proportion of patients (5–10%) who achieve suboptimal results from the primary procedure may benefit from injectable vocal fold augmentation, revision thyroplasty with implant resizing, or the addition of arytenoid adduction as a secondary procedure.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides a fully integrated, non-medical support infrastructure designed to eliminate the logistical burden of international medical travel, allowing patients to focus entirely on their recovery.
VISA & DOCUMENTATION:
• India: GAF Healthcare's visa assistance team guides patients through the e-Medical Visa application process (available to citizens of 150+ countries), which is typically granted within 3–5 business days. Required documents — physician referral letter, hospital appointment confirmation, and passport details — are collated and formatted by GAF's team. Attendants traveling with the patient are simultaneously processed for the e-Medical Attendant Visa.
• UAE (Dubai / Abu Dhabi): Citizens of most Western, GCC, and many Asian countries enjoy visa-on-arrival or visa-free access to the UAE for up to 30–90 days. For nationalities requiring advance visas, GAF Healthcare coordinates a medical visa or tourist visa application through its UAE network partners, with standard processing in 3–7 business days.
AIRPORT & GROUND TRANSFERS:
• Dedicated, air-conditioned vehicle pickup from the international airport at any hour, coordinated in real time with the patient's flight.
• All inter-facility transfers (hotel to hospital, hospital to diagnostic center, hospital to airport at discharge) are scheduled and managed by GAF Healthcare's local operations team.
ACCOMMODATION:
• For patients not requiring continuous in-hospital stay, GAF Healthcare arranges partner hotels within 5–10 minutes of the treating hospital, offering medical-tourism-friendly amenities (dietary options, hygiene standards appropriate for immunocompromised or post-surgical patients).
• Dedicated rooms or suites for the patient's attendant/caregiver are arranged simultaneously, with negotiated rates.
LANGUAGE & CULTURAL SUPPORT:
• Certified medical interpreters and patient liaison officers are available in Arabic, Russian, French, Swahili, and other major languages, accompanying patients at consultations, consent signings, and post-operative briefings.
• Cultural and dietary preferences are communicated to hospital dietary teams in advance.
CONTINUITY OF CARE:
• GAF Healthcare provides patients with a dedicated Case Manager who coordinates between the treating surgical team, the patient's home-country physician, and the patient themselves throughout the entire journey — from initial inquiry through post-operative telemedicine follow-up.
• All medical records, operative notes, imaging, and post-operative instructions are compiled into a structured digital discharge package, formatted for international handover to the patient's local healthcare provider.